Promising cream may ease rare skin lesions

NCT ID NCT03972592

Completed Disease control Sponsor: University Hospital, Tours Source: ClinicalTrials.gov ↗

First seen Feb 15, 2026 · Last updated May 16, 2026 · Updated 8 times

Summary

This study tested a cream containing sirolimus on rare skin growths called microcystic lymphatic malformations. 55 children and adults applied the cream to one area and a placebo to another for 12 weeks. The goal was to see if the active cream reduces the severity of the lesions better than the placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

ANGERS

Angers, France
BORDEAUX

Bordeaux, France
CAEN

Caen, France
DIJON

Dijon, France
LYON AD

Bron, France
LYON PED

Bron, France
Lariboisiere

Paris, France
Marseille

Marseille, France
Montpellier

Montpellier, France
NANCY

Vandœuvre-lès-Nancy, France
NANTES

Nantes, France
NECKER

Paris, France
NICE

Nice, France
QUIMPER

Quimper, France
RENNES

Rennes, France
TOULOUSE

Toulouse, France
TOURS

Tours, France

Conditions

Explore the condition pages connected to this study.

LYMPHATIC MALFORMATION LYMPHATIC MALFORMATION VASCULAR MALFORMATIONS